Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diazoxide for Obesity in Children with Hypothalamic-Pituitary Lesions
NCT00306683Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Apr 2006
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in obesity and hyperinsulinemia comparing Diazoxide with Placebo (2 arms). Primary endpoint: Relative weight change at 2 months. Started Apr 2006; status: completed.
02
Drugs
diazoxide
03
Conditions
obesityhyperinsulinemia
Beyond the preview
Go deeper on NCT00306683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00306683.